Former Aastrom CEO returns to Esperion Theraputics in Plymouth Township

Posted on Fri, Jan 4, 2013 : 11:57 a.m.

Former Aastrom CEO returns to Esperion Theraputics in Plymouth Township

By Ben Freed

The leadership team of one of the most successful pharmaceutical startups in Michigan history is reuniting, according to a report in Crain’s Detroit Business.

Mayleben served as CEO of Aastrom in Ann Arbor from 2009-2012.

File photo | AnnArbor.com

Tim Mayleben is returning to Plymouth Township-based Esperion Theraputics, which was bought by Pfizer and then sold back to founder Roger Newton in 2008. Mayleben was chief operating and financial officer at the original Esperion and will be returning as CEO and president.

Newton, who raised nearly $23 million to relaunch the company, will step aside as CEO and take on chief science officer and executive chairmen roles. Mayleben had been CEO and president of Ann Arbor pharma company Aastrom Biosciences until he left in December.

Click here for the full report from Crain’s Detroit Business.

Ben Freed covers business for AnnArbor.com. You can sign up here to receive Business Review updates every week. Reach out to Ben at 734-623-2528 or email him at benfreed@annarbor.com. Follow him on twitter @BFreedinA2

Comments

cdfa2

Fri, Jan 4, 2013 : 5:23 p.m.

Hmm. "Most successful biopharmaceutical startup" based on what? What new medicines has Esperion produced in 15 years? The investors and executives have sure made a lot of money.